Jennifer Margarita Cuellar-rodríguez - Infectious Diseases

Author Information

Jennifer Margarita Cuellar-Rodríguez is a distinguished researcher affiliated with the Department of Infectious Diseases at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán located in Mexico City, Mexico. Her work primarily revolves around infectious diseases with a particular focus on transplantation and immunological responses. Her contributions to this field are well-regarded, reflecting her expertise and commitment to advancing medical knowledge and treatment methodologies.

Research Contributions

Jennifer Cuellar-Rodríguez has made significant contributions to the field of transplantation and infectious diseases, as evidenced by her numerous publications. Her research often explores the intricacies of hematopoietic cell transplantation, particularly in the context of immune deficiencies and post-transplantation complications such as cytomegalovirus disease. She has also investigated the role of cyclophosphamide in transplantation, striving to optimize dosing to improve patient outcomes. Her work is influential in understanding the management of febrile neutropenia and the implications of GATA2 deficiency in transplant patients.

Aliases

Throughout her career, Jennifer Margarita Cuellar-Rodríguez has been recognized under various aliases, including J. Cuellar-Rodríguez, Jennifer M. Cuellar-Rodríguez, and Jennifer Cuellar-Rodriguez, among others. These variations often appear in academic and professional settings, reflecting the common practice of using abbreviated forms of names in scholarly publications.

Publication and Citation Metrics

Metric	Value
Citation Count	2805
H-index	19
Paper Count	70

Publications:

Phase I/II Study Reducing Post-Transplantation Cyclophosphamide Dosing after Myeloablative HLA-Haploidentical Bone Marrow Transplantation

DOI: 10.1016/s2666-6367(22)00548-6

Year: 2022

Prospective Clinical Trial of Mycophenolate Mofetil (MMF) De-Escalation in Allogeneic Hematopoietic Cell Transplantation (HCT) for Primary Immunodeficiency (PID): MMF Is Dispensable in Reduced-Intensity Conditioning, Posttransplantation Cyclophosphamide(PTCy)-Based HCT

DOI: 10.1016/s2666-6367(22)00177-4

Year: 2022

Incidence of Cytomegalovirus disease and viral replication kinetics in seropositive liver transplant recipients managed under preemptive therapy in a tertiary-care center in Mexico City: a retrospective cohort study

DOI: 10.1186/s12879-022-07123-w

Year: 2022

Febrile neutropenia management and outcomes in hematopoietic cell transplantation for chronic granulomatous disease

DOI: 10.1111/tid.13815

Year: 2022

Immunology of Fungal Infections.

DOI: 10.1016/j.idc.2021.03.006

Year: 2021

Phase I/II Study of Reduced Dosing of Post-Transplantation Cyclophosphamide (PTCy) after HLA-Haploidentical Bone Marrow Transplantation

DOI: 10.1182/blood-2021-146997

Year: 2021

Phase I Study De-Intensifying Exposure of Post-Transplantation Cyclophosphamide (PTCy) after HLA-Haploidentical Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies

DOI: 10.1016/S2666-6367(21)00037-3

Year: 2021

Donor source and post‐transplantation cyclophosphamide influence outcome in allogeneic stem cell transplantation for GATA2 deficiency

DOI: 10.1111/bjh.17840

Year: 2021

Pulmonary Manifestations of GATA2 Deficiency.

DOI: 10.1016/j.chest.2021.05.046

Year: 2021

Hematopoietic Cell Transplantation and Outcomes Related to Human Papillomavirus Disease in GATA2 Deficiency.

DOI: 10.1016/j.jtct.2020.12.028

Year: 2021

Why is the Apicoplast Important in Infectious Diseases?

How Do Bacteria Become Resistant?

Can Antivirals Be Used for Prevention?

What Role Do Healthcare Professionals Play?

What are the Future Directions in Antimicrobial Therapies?

What is the Role of Vector Control in Combating Malaria?

What Are the Benefits of Personalized Medicine in Infectious Diseases?

How Does Genomic Sequencing Aid in Disease Surveillance?

What Current Research is Being Conducted?

How is Plasmodium falciparum transmitted?

Partnered Content Networks

Relevant Topics